Healthcare / Medical Care FacilitiesTokyo
$1236.00
-14.00 (-1.12%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $465.8M · quality 64.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.0B
P/E
6.9x
↓EV/EBITDA
4.2x
↓ROE
11.2%
↑Gross Margin
15.5%
↓Debt/Equity
0.80
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.1%
FCF CAGR
-2.0%
FCF margin
7.4%
FCF / Net income
2.00x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.97B · net income $406.4M · FCF $812.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.97B | $10.97B | $10.36B | $9.62B | $9.19B |
| Net Income | $406.4M | $406.4M | $523.4M | $444.9M | $528.7M |
| EBITDA | $1.02B | $1.02B | $1.16B | $1.05B | $1.07B |
| EPS | 152.00 | 152.00 | 195.60 | 167.39 | 240.32 |
| Gross Margin | 15.5% | 15.5% | 14.4% | 16.2% | 16.9% |
| Operating Margin | 6.0% | 6.0% | 5.1% | 5.7% | 7.1% |
| Net Margin | 3.7% | 3.7% | 5.1% | 4.6% | 5.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.80 | 0.80 | 1.06 | 1.27 | 1.89 |
| Current Ratio | 1.63 | 1.63 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $812.9M | $812.9M | $465.8M | $207.5M | $864.8M |
| Returns | |||||
| ROE | 11.2% | 11.2% | 15.0% | 14.6% | 26.3% |
| Valuation | |||||
| P/E | 6.91 | 6.91 | 5.66 | 6.96 | 6.79 |
| EV/EBITDA | 4.17 | 4.17 | 3.69 | 4.36 | 5.25 |
| P/B | 0.91 | 0.91 | 0.85 | 1.02 | 1.79 |
| Growth & Yield | |||||
| Revenue Growth | 5.9% | 5.9% | 7.7% | 4.7% | — |
| EPS Growth | -22.3% | -22.3% | 16.9% | -30.3% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-10.3%
EPS terminal req.
$109.67
Spread vs growth
-12.0%
5Y implied EPS CAGR
-2.7%
EPS terminal req.
$132.71
Spread vs growth
-19.6%
10Y implied EPS CAGR
3.5%
EPS terminal req.
$213.72
Spread vs growth
-25.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+27.7%
Start / end P/E
5.1x → 8.1x
EPS bridge
195.60 → 152.00
Residual
-13.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.